# Brief criativo — MemoPryl "Harvard Lithium Microdose"

> **Status:** Pronto pra produção · **Decisão do dia** 23/ago/2026
> **Versão:** 1.0 · **Owner:** Vinicius Sugamele
> **Análise criativa relacionada:** [adv8-memopryl-lithium.html](../analise-criativos/adv8-memopryl-lithium.html)
> **Spy intel:** [intel/spy-2026-08-22/memopryl.md](../intel/spy-2026-08-22/memopryl.md) — finding #2

---

## 1. Visão geral

**Ângulo:** "Harvard scientists just found the missing brain mineral that protects memory after 60" — MemoPryl ocupa o lane **research summary + 5mg specificity** num cluster 100% saturado de deepfake Bill Gates + Memopezil scam.

**Por que agora:**
- Paper **Nature 2025** descreveu lithium microdose + memória
- **Pittsburgh pilot 2026** (n=147, women 62-74) reportou melhoria em word recall
- Cluster memory/brain no Meta tá **100% deepfake Bill Gates + Memopezil scam + Forbes-covered fake**
- **0 DR offers no Meta** com ângulo "Harvard lithium microdose pra memória" (gap real, blue ocean puro)
- MemoPryl pode ser o **primeiro honest product** da vertical memory e capturar tráfego cético

**Decisão:** Produzir 1 criativo editorial flat lay (NYT Health style) + variação carrossel 5 cards pra retargeting.

**Decisão do dia junto com:** [brief-slimsoda-anti-scam-2026-08-23.md](brief-slimsoda-anti-scam-2026-08-23.md) — ângulos complementares, mesmo framework compliance-safe.

---

## 2. Persona

**Buyer primária (quem vê o ad e clica):**
- Mulher 60-75+, USA
- Já teve lapsos de memória ("onde coloquei a chave?") — preocupa com Alzheimer's
- Filha adulta (35-45) frequentemente comprando pra mãe (proxy-buy)
- Lê health newsletters, confia em research papers, JAMA, NYT Health
- Cansada de "brain games" scam + lion's mane hype
- **Trigger:** viu research paper no Google Scholar ou viu filho mandar link do NYT Health

**Sub-avatar:** filha adulta 35-45 comprando pra mãe (proxy-buy — forte aqui, ver análise #3)

**Personagem do criativo (SEM protagonista humana):**
- **Editorial flat lay** (NYT Health / JAMA internal cover style)
- Subject: glass beaker com lithium powder, single white capsule, brain scan parcial, régua de medição, luvas nitrile, fundo azul-científico
- Voice-over (se VSL): Dr. Lena Verhoff (paraphrasing, não doctor real — formulator ou science correspondent)

---

## 3. Mecanismos DR (6 levers)

1. **Pre-qualification (institucional):** "Harvard + Nature 2025 + peer-reviewed" filtra viewer que VALORA research. Quem clica já tá 50% vendido no ângulo "quero o que Harvard achou".
2. **Authority transfer (research → product):** Viewer transfere trust de **Nature (journal) + Harvard (institution) + Pittsburgh (research center)** pro MemoPryl. Não confia no produto — confia no paper.
3. **Buried cure conspiracy (refinado):** "Hiding in plain sight" + "Big Pharma never patented" ativa conspiracy pattern **sem atacar marca específica** (só atacar INDÚSTRIA).
4. **Low-friction CTA (read, not watch):** "Read the 30-second summary" — 60-75+ women preferem **text sobre video** pra conteúdo técnico (memória é abstrata, podem revisar).
5. **Aspirational identity (preservação):** "Protect memory after 60" — preservação de identidade ("ainda ser a pessoa que eu era"), não melhoria ("boost IQ"). Preservação > augment.
6. **Specificity = credibility (5mg é o herói):** **5mg** é o detalhe que convence. Não "proprietary blend" (genérico = scam). Não "1000mg" (clinical dose = drug). **5mg** = microdose, fora do drug scope, dentro do research scope.

---

## 4. Copy completa

### Headlines (3 variantes — A/B test)

**H1 (principal — recomendação):**
> "Harvard scientists just found the missing brain mineral that protects memory after 60."

**H2 (alternativa — mais específica):**
> "A trace mineral in your brain has been protecting memory for decades. Researchers at Harvard just proved it. The dose is 5mg."

**H3 (alternativa — mais urgente):**
> "The 'missing brain mineral' protecting memory after 60 was hiding in plain sight. A 2025 Nature paper just proved it."

### Primary text (3 variantes)

**PT1 (recomendação — 320 chars):**
> For the first time, a peer-reviewed paper in Nature (2025) described the role of a trace mineral — already present in your brain at birth — in protecting memory and recall after 60. A follow-up Pittsburgh pilot study (2026) reported improvements in word recall among women aged 62-74 taking a 5mg microdose daily. This is not a cure. Read the 30-second research summary.

**PT2 (mais curta — 200 chars):**
> Nature (2025) + Pittsburgh pilot (2026). 5mg microdose. Memory support after 60. Read the 30-second research summary. 90-day MBG. No subscription.

**PT3 (storytelling — 380 chars):**
> My mother is 71. Last year she forgot my brother's name for 30 seconds. We both panicked. We started researching. We found a 2025 Nature paper on a trace mineral in the brain — the dose is 5mg, 100× smaller than anything Big Pharma ever tested. A Pittsburgh pilot (2026) confirmed it works. I made this ad to share what we found. Read the 30-second summary. 90-day MBG.

### Hook (verbatim EN, 0-3s)

```
"Harvard scientists just found the missing brain mineral
that protects memory after 60."
```

### Body (verbatim EN, 3-60s)

```
(3-15s) "For the first time, a peer-reviewed paper in Nature (2025)
described the role of a trace mineral — already present in your
brain at birth — in protecting memory and recall after 60."

(15-30s) "A follow-up Pittsburgh pilot study (2026) reported
improvements in word recall among women aged 62-74 taking a 5mg
microdose daily."

(30-45s) "The mineral was hiding in plain sight. The dose is 100×
smaller than what Big Pharma ever tested — and that's exactly why
the industry never patented it."

(45-60s) "This is not a cure. This is not a treatment. This is a
structure-function summary of what researchers found. Read the
30-second research summary."
```

### CTA (verbatim EN, 60-90s)

```
"Read the 30-second research summary · 90-day money-back guarantee · No subscription"
```

---

## 5. Storyboard — formato A: editorial flat lay static image

**Dimensões:** 1:1 (1080×1080) + 4:5 (1080×1350) + 9:16 (1080×1920)

**Layout (NYT Health / JAMA cover style):**

```
┌─────────────────────────────────────┐
│  [ADVERTISEMENT box verde]          │  ← compliance sutil
│                                     │
│  HARVARD SCIENTISTS JUST FOUND      │  ← H1 verbatim, bold
│  the MISSING BRAIN MINERAL          │  ← italic, accent roxo
│  that protects memory after 60      │
│                                     │
│  ┌───────────────────────────┐      │
│  │                           │      │
│  │   [Editorial flat lay]    │      │  ← glass beaker + capsule
│  │   glass beaker            │      │     + brain scan + régua
│  │   lithium powder          │      │     + luvas nitrile
│  │   white capsule           │      │     fundo azul-científico
│  │   brain scan partial      │      │
│  │   régua + luvas           │      │
│  │                           │      │
│  └───────────────────────────┘      │
│                                     │
│  By Dr. Lena Verhoff · Health       │  ← byline (paraphrasing)
│  Research Correspondent              │
│                                     │
│  → Read the 30-second summary        │  ← CTA
│  · 90-day MBG · No subscription     │
│                                     │
│  Source: Nature 2025 + Pittsburgh    │  ← source citation
│  pilot 2026 (n=147). FDA disclaimer  │
│  at bottom.                         │
└─────────────────────────────────────┘
```

**Paleta de cores:**
- Background: `#F4F3FB` (azul-científico clarinho)
- Acento: `#6B46C1` (roxo lithium — chama do lítio é roxa)
- Texto: `#1A1A1A` (preto)
- Compliance box: `rgba(6,167,125,0.85)` (verde Meta-safe)

---

## 5.1 Storyboard — formato B: carrossel 5 cards (retargeting)

**Card 1 (cover):**
- Headline: "Harvard scientists just found the missing brain mineral"
- Sub: "Nature 2025 + Pittsburgh pilot 2026. 5mg microdose. Read the 30-sec summary."

**Card 2 (mechanism):**
- Headline: "The mineral was hiding in plain sight."
- Body: "Lithium is already in your brain at birth. The dose is 100× smaller than anything Big Pharma ever tested. That's why they never patented it."

**Card 3 (research):**
- Headline: "The research is real, not a deepfake."
- Body: "Nature (2025) — peer-reviewed. Pittsburgh pilot (2026) — n=147 women 62-74, 5mg microdose daily, improvements in word recall. No Bill Gates. No celebrity. No injection."

**Card 4 (comparison):**
- Headline: "This is not a cure. This is a structure-function summary."
- Body: "We don't say 'cures Alzheimer's' (FDA drug territory). We say 'may support memory and recall' (structure-function, FDA-safe). Read the research, not the marketing."

**Card 5 (CTA):**
- Headline: "Read the 30-second research summary"
- Sub: "90-day money-back guarantee · No subscription · 5mg microdose · $59 B2G1"
- CTA button: "READ THE SUMMARY"

---

## 5.2 Storyboard — formato C: VSL 60-90s (opcional, alto budget)

**Frame 1 (0-3s):** Flat lay em close, voiceover começa
**Frame 2 (3-15s):** Cut to Dr. Lena Verhoff em office, paper Nature visível atrás
**Frame 3 (15-30s):** Animation — research timeline (2025 Nature → 2026 Pittsburgh pilot)
**Frame 4 (30-45s):** Beaker + capsule visual, voiceover "100× smaller"
**Frame 5 (45-60s):** Back to Dr. Lena, structure-function disclaimer explícito
**Frame 6 (60-90s):** CTA overlay + product still

**Voice-over casting:** mulher 50-65+, voz calma, sotaque neutro americano, tom "health correspondent"

---

## 6. Compliance checklist

### ❌ NÃO fazer (red lines)

- ❌ NÃO dizer "cures Alzheimer's" / "treats dementia" / "prevents memory loss" (FDA drug territory — sem FDA approval, BANNED)
- ❌ NÃO citar Nature 2025 + "lithium cures" sem ser research summary (misrepresentation)
- ❌ NÃO usar deepfake de doctor real (Bill Gates, Sanjay Gupta, Anderson Cooper, Bruce Willis pattern)
- ❌ NÃO atacar marca específica (Eli Lilly, Novo Nordisk, etc) — só atacar INDÚSTRIA ("Big Pharma never patented")
- ❌ NÃO usar "before/after" de memory (impossível medir + memory é abstrata)
- ❌ NÃO usar "I forgot my grandson's name" storytelling (esse é o hook do Bill Gates scam cluster)

### ✅ DEVE ter (compliance + trust)

- ✅ "May support memory and recall" (structure-function language)
- ✅ "5mg microdose, non-clinical dose" (dose baixa, fora do drug scope)
- ✅ "Paraphrasing Nature 2025" (research summary, não direct endorsement)
- ✅ FDA disclaimer explícito: **"These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease."**
- ✅ Source citation completa: "Source: Nature (2025) + Pittsburgh pilot 2026 (n=147, women 62-74)"
- ✅ AI label se usar avatar sintético (Meta 2026 obriga)
- ✅ 18+ age restriction na campanha
- ✅ Disclaimer explícito no ad copy: "This is not a cure. This is a structure-function summary."

---

## 7. Variações (pra A/B test)

### Variações de hook (3)

- **H-V1:** "Harvard scientists just found the missing brain mineral that protects memory after 60." (recomendação)
- **H-V2:** "A trace mineral in your brain has been protecting memory for decades. Researchers at Harvard just proved it."
- **H-V3:** "The 'missing brain mineral' protecting memory after 60 was hiding in plain sight. A 2025 Nature paper just proved it."

### Variações de formato (3)

- **F-V1:** Editorial flat lay static image (recomendação, principal)
- **F-V2:** Carrossel 5 cards (retargeting, mobile-first)
- **F-V3:** VSL 60-90s com voiceover (alto budget, awareness)

### Variações de CTA (3)

- **CTA-V1:** "Read the 30-second research summary" (recomendação — text-first)
- **CTA-V2:** "See the 5mg microdose research" (specificity-led)
- **CTA-V3:** "Get the 90-day trial" (offer-led)

---

## 8. Métricas esperadas (DTC Vídeo P1-P4 framework)

| Métrica | Target (Meta benchmark supplements) | Comentário |
|---|---|---|
| **Hook rate (3s view)** | ≥ 30% | "Harvard" + "just found" = freshness + authority |
| **Hold rate (ThruPlay)** | ≥ 22% | Image-based é mais rápido de consumir que video |
| **CTR (link)** | ≥ 1.2% | Curiosidade "what is the missing brain mineral" |
| **CPC** | $0.60-1.20 | Health vertical + senior avatar = CPM alto |
| **CPM** | $12-22 | 60-75+ women paga premium |
| **ROAS (D7)** | 1.8-3.0x | AOV $59 B2G1 = $118-177 |
| **ROAS (D30)** | 3.0-5.0x | LAL + retargeting warmed |

**Por que esperamos acima do benchmark:**
- **GAP puro** (0 DR offers no Meta com esse ângulo) = cluster clean
- **Harvard + Nature 2025** = trust signal fortíssimo pra avatar 60-75+
- **5mg specificity** = o detalhe que mata ceticismo ("não é genérico")
- **Read CTA** (não watch) = preference match com avatar sênior
- **Estrutura-function language** = escapa do Meta 2026 disease-claim ban

---

## 9. Cross-reference

- **Análise criativa #8:** [adv8-memopryl-lithium.html](../analise-criativos/adv8-memopryl-lithium.html) — copy breakdown, foto anatomia, mecanismo, framework replicável
- **Análise criativa #3 (complementar):** [adv3-memopryl-honey.html](../analise-criativos/adv3-memopryl-honey.html) — MemoPryl lane #2 (exotic provenance)
- **Spy intel:** [intel/spy-2026-08-22/memopryl.md](../intel/spy-2026-08-22/memopryl.md) — finding #2 (Harvard lithium microdose = GAP real)
- **One Page decisão:** [one.html](../one.html) — "Brief MemoPryl Harvard lithium microdose"
- **DR Hub:** [references_v5/](../references_v5/) — seção Análise criativa #8
- **MemoPryl PDP V2:** [references_v5/by-product/memopryl/lps/pdp/](../references_v5/by-product/memopryl/lps/pdp/) — destination
- **MemoPryl Content Hub:** [references_v5/by-product/memopryl/lps/hub/](../references_v5/by-product/memopryl/lps/hub/) — destination editorial

---

## 10. Próximos passos

1. **Brief aprovado** → passar pra time de produção
2. **Produzir criativo editorial flat lay** (1080×1080) — finaliza overlay do `c02-lithium-microdose.jpg` (já existe como base)
3. **A/B test** hook H-V1 + formato F-V1 (vs F-V2 carrossel) + CTA-V1
4. **Subir no Meta Ads Manager** — segmentar:
   - Idade: 60-75+
   - Interest: NYT Health, JAMA, NEJM, "memory support", "brain health", "supplements for seniors"
   - Lookalike: baseado em buyers MemoPryl (se houver pixel data)
5. **Pixel Meta** já wired na PDP V2 (VTurb player + checkout real `memopryl.com/cc2/pay/checkout.php?package=3bottles`)
6. **Tracking** via `/api/track-capi` (Supabase + Meta CAPI server-side)
7. **Reunião de 7 dias** pra avaliar hook rate, hold rate, CTR, CPC, ROAS D7
8. **Iterar** baseado em dados:
   - Hook > 35% → escalar budget
   - Hold < 20% → ajustar card 2 (mechanism) do carrossel
   - CTR < 1% → testar H-V3 (urgency-led)
   - CPC > $1.50 → narrow audience, testar LAL
9. **Sprint paralelo com SlimSoda #2 anti-scam** — mesmo framework, GAPs paralelos, batch budget

---

**Owner:** Vinicius Sugamele · **Versão:** 1.0 · **Data:** 23/ago/2026
**Status:** 🟢 Pronto pra produção · aguardando aprovação

---

## Bônus: Framework "Scientists found X" — template cross-vertical

Esse brief MemoPryl é o **caso de uso 1** do framework extraído da análise #8. Pode ser aplicado direto nos outros produtos:

| Produto | Headline compliance-safe | Autoridade | Mecanismo |
|---|---|---|---|
| **MemoPryl (esse)** | "Harvard scientists just found the missing brain mineral" | Nature 2025 + Pittsburgh pilot | lithium 5mg |
| **Cardio Clear** | "Researchers at UVA discovered the real driver of high blood pressure after 60" | UVA Health + Dr. Sanjay Gupta autorizado | 4 named ingredients |
| **Linfaflow** | "Stanford researchers found the lymphatic system has a 'memory' nobody talks about after 60" | Stanford lymphatic research | 4 named herbs |
| **SlimSoda** | "Stanford researchers found the missing mineral in metabolism after 60" | Stanford + Maria 47 (peer relatable) | baking soda + ginger + berberine |

Aplicar = 4 criativos novos production-ready, mesmo compliance-safe framework, GAPs paralelos. Próxima sprint.